Home›Companies›Biotech & Pharma›Affini-T Therapeutics

Affini-T Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 15, 2024·Suggest an edit

About Affini-T Therapeutics

Affini-T Therapeutics is a private company based in Watertown, Massachusetts, incorporated in 2020 in Delaware. It has reported $17,617,952 raised in one offering on Form D since October 2024. Its chief executive is Joseph Knowles.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 31, 2024Oct 15, 2024$17,617,952fully sold65$271KEquity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Affini-T Therapeutics's Form D filed Oct 15, 2024.

LI
KB
Kathy Bergsteinsson
Executive officer
JD
DF
Daniel Faga
Director
AG
Arjun Goyal
Director
MV
JK
Joseph Knowles
Chief Executive Officer and director
KY
Kathy Yi
Executive officer

Sources

  1. SECAffini-T Therapeutics, Inc. filing history